155 related articles for article (PubMed ID: 36362115)
1. The Association between Cyclin Dependent Kinase 2 Associated Protein 1 (CDK2AP1) and Molecular Subtypes of Lethal Prostate Cancer.
Gamallat Y; Bakker A; Khosh Kish E; Choudhry M; Walker S; Aldakheel S; Seyedi S; Huang KC; Ghosh S; Gotto G; Bismar TA
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362115
[TBL] [Abstract][Full Text] [Related]
2. High Serine-arginine Protein Kinase 1 Expression with PTEN Loss Defines Aggressive Phenotype of Prostate Cancer Associated with Lethal Outcome and Decreased Overall Survival.
Abou-Ouf H; Assem H; Ghosh S; Karnes RJ; Stoletov K; Palanisamy N; Lewis JD; Bismar TA
Eur Urol Open Sci; 2021 Jan; 23():1-8. PubMed ID: 34337483
[TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of combined ERG and androgen receptor expression in patients with prostate cancer managed by androgen deprivation therapy.
Huang KC; Alshalalfa M; Hegazy SA; Dolph M; Donnelly B; Bismar TA
Cancer Biol Ther; 2014 Sep; 15(9):1120-8. PubMed ID: 24972028
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of CDK2AP1 in primary human fibroblasts induces p53 dependent senescence.
Alsayegh KN; Gadepalli VS; Iyer S; Rao RR
PLoS One; 2015; 10(3):e0120782. PubMed ID: 25785833
[TBL] [Abstract][Full Text] [Related]
5. Combined loss of TFF3 and PTEN is associated with lethal outcome and overall survival in men with prostate cancer.
Abou-Ouf H; Ghosh S; Box A; Palanisamy N; Bismar TA
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1751-1759. PubMed ID: 31129769
[TBL] [Abstract][Full Text] [Related]
6. Cell cycle regulator cdk2ap1 inhibits prostate cancer cell growth and modifies androgen-responsive pathway function.
Zolochevska O; Figueiredo ML
Prostate; 2009 Oct; 69(14):1586-97. PubMed ID: 19585490
[TBL] [Abstract][Full Text] [Related]
7. Decreased ATM Protein Expression Is Substantiated with PTEN Loss in Defining Aggressive Phenotype of Prostate Cancer Associated with Lethal Disease.
Walker SR; Abdelsalam R; Ghosh S; Livingstone J; Palanisamy N; Boutros PC; Yip SM; Lees-Miller SP; Bismar TA
Eur Urol Open Sci; 2021 Jul; 29():93-101. PubMed ID: 34337539
[TBL] [Abstract][Full Text] [Related]
8. Clinical aggressiveness of myxofibrosarcomas associates with down-regulation of p12CDK2AP1: prognostic implication of a putative tumor suppressor that induces cell cycle arrest and apoptosis via mitochondrial pathway.
Li CF; Huang HY; Wu WR; Liang SS; Chen YL; Chen LR; Peng YT; Lee HC; Shiue YL
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S711-20. PubMed ID: 24889487
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of assessing PTEN and ERG protein expression in prostate cancer patients: a proposed method for risk stratification.
Bismar TA; Hegazy S; Feng Z; Yu D; Donnelly B; Palanisamy N; Trock BJ
J Cancer Res Clin Oncol; 2018 Nov; 144(11):2117-2125. PubMed ID: 30101374
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in prostate cancer.
Stattin P
Scand J Urol Nephrol Suppl; 1997; 185():1-46. PubMed ID: 9249905
[TBL] [Abstract][Full Text] [Related]
11. A natural androgen receptor antagonist induces cellular senescence in prostate cancer cells.
Hessenkemper W; Roediger J; Bartsch S; Houtsmuller AB; van Royen ME; Petersen I; Grimm MO; Baniahmad A
Mol Endocrinol; 2014 Nov; 28(11):1831-40. PubMed ID: 25203674
[TBL] [Abstract][Full Text] [Related]
12. Cyclin-dependent kinase 2-associated protein 1 suppresses growth and tumorigenesis of lung cancer.
Sun M; Jiang R; Wang G; Zhang C; Li J; Jin C; Zhang X
Int J Oncol; 2013 Apr; 42(4):1376-82. PubMed ID: 23404055
[TBL] [Abstract][Full Text] [Related]
13. p53 and cyclooxygenase-2 expression are directly associated with cyclin D1 expression in radical prostatectomy specimens of patients with hormone-naïve prostate cancer.
Vlachostergios PJ; Karasavvidou F; Patrikidou A; Voutsadakis IA; Kakkas G; Moutzouris G; Zintzaras E; Daliani DD; Melekos MD; Papandreou CN
Pathol Oncol Res; 2012 Apr; 18(2):245-52. PubMed ID: 21786090
[TBL] [Abstract][Full Text] [Related]
14. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
Navone NM; Rodriquez-Vargas MC; Benedict WF; Troncoso P; McDonnell TJ; Zhou JH; Luthra R; Logothetis CJ
Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751
[TBL] [Abstract][Full Text] [Related]
15.
Rezk M; Chandra A; Addis D; Møller H; Youssef M; Dasgupta P; Yamamoto H
BMJ Open; 2019 Mar; 9(3):e025161. PubMed ID: 30852544
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of CDK2AP1 in human embryonic stem cells reduces the threshold of differentiation.
Alsayegh KN; Sheridan SD; Iyer S; Rao RR
PLoS One; 2018; 13(5):e0196817. PubMed ID: 29734353
[TBL] [Abstract][Full Text] [Related]
17. Targeting cyclin-dependent kinase 7-association between CDK7 and pMED1 expression in prostate cancer tissue.
Paulsen FO; Kang D; Becker F; Roth D; Joerg V; Dreyer E; Roesch MC; Seidel C; Merseburger AS; Kirfel J; Sailer V; Offermann A; Perner S
Carcinogenesis; 2022 Sep; 43(8):779-786. PubMed ID: 35512686
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of abnormal p53 expression in locally advanced prostate cancer treated with androgen deprivation and radiotherapy: a study based on RTOG 9202.
Che M; DeSilvio M; Pollack A; Grignon DJ; Venkatesan VM; Hanks GE; Sandler HM;
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1117-23. PubMed ID: 17689883
[TBL] [Abstract][Full Text] [Related]
19. ING3 is associated with increased cell invasion and lethal outcome in ERG-negative prostate cancer patients.
Almami A; Hegazy SA; Nabbi A; Alshalalfa M; Salman A; Abou-Ouf H; Riabowol K; Bismar TA
Tumour Biol; 2016 Jul; 37(7):9731-8. PubMed ID: 26803516
[TBL] [Abstract][Full Text] [Related]
20. ncRNA-mediated overexpression of ubiquitin-specific proteinase 13 contributes to the progression of prostate cancer via modulating AR signaling, DNA damage repair and immune infiltration.
Cui X; Yu H; Yao J; Li J; Li Z; Jiang Z
BMC Cancer; 2022 Dec; 22(1):1350. PubMed ID: 36564767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
